Lilla Nagy

570 total citations
18 papers, 465 citations indexed

About

Lilla Nagy is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Lilla Nagy has authored 18 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Surgery. Recurrent topics in Lilla Nagy's work include PARP inhibition in cancer therapy (5 papers), Adipose Tissue and Metabolism (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). Lilla Nagy is often cited by papers focused on PARP inhibition in cancer therapy (5 papers), Adipose Tissue and Metabolism (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). Lilla Nagy collaborates with scholars based in Hungary, United States and Switzerland. Lilla Nagy's co-authors include Péter Bai, Tamás Fodor, Magdolna Szántó, Borbála Kiss, Attila Brunyánszki, Pál Pacher, Pál Gergely, Lucas Liaudet, László Virág and Judit Márton and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and British Journal of Pharmacology.

In The Last Decade

Lilla Nagy

18 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lilla Nagy Hungary 10 249 214 65 65 53 18 465
Jatinder Singh United States 13 190 0.8× 125 0.6× 25 0.4× 21 0.3× 64 1.2× 37 430
Yung‐Lung Chang Taiwan 15 360 1.4× 71 0.3× 63 1.0× 38 0.6× 37 0.7× 32 566
Olga Alster Poland 8 263 1.1× 96 0.4× 56 0.9× 187 2.9× 23 0.4× 9 490
Krisztián Erős Hungary 10 170 0.7× 94 0.4× 34 0.5× 37 0.6× 34 0.6× 14 327
Katalin Hantó Hungary 9 216 0.9× 184 0.9× 27 0.4× 22 0.3× 19 0.4× 10 404
Haoran Qian China 9 238 1.0× 203 0.9× 183 2.8× 37 0.6× 26 0.5× 28 618
Juhyung Woo United States 11 270 1.1× 87 0.4× 129 2.0× 68 1.0× 15 0.3× 26 507
Peng Meng China 13 383 1.5× 140 0.7× 92 1.4× 43 0.7× 57 1.1× 22 649
Yuqin Wang China 16 385 1.5× 46 0.2× 89 1.4× 43 0.7× 37 0.7× 26 663
Chenzhong Xu China 14 339 1.4× 81 0.4× 48 0.7× 81 1.2× 30 0.6× 24 539

Countries citing papers authored by Lilla Nagy

Since Specialization
Citations

This map shows the geographic impact of Lilla Nagy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lilla Nagy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lilla Nagy more than expected).

Fields of papers citing papers by Lilla Nagy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lilla Nagy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lilla Nagy. The network helps show where Lilla Nagy may publish in the future.

Co-authorship network of co-authors of Lilla Nagy

This figure shows the co-authorship network connecting the top 25 collaborators of Lilla Nagy. A scholar is included among the top collaborators of Lilla Nagy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lilla Nagy. Lilla Nagy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Nagy, Lilla, et al.. (2024). Role of Protein Phosphatases in Tumor Angiogenesis: Assessing PP1, PP2A, PP2B and PTPs Activity. International Journal of Molecular Sciences. 25(13). 6868–6868. 1 indexed citations
3.
Nagy, Lilla, László Juhász, Tündé Kovàcs, et al.. (2020). Glycogen phosphorylase inhibitor, 2,3‐bis[(2E)‐3‐(4‐hydroxyphenyl)prop‐2‐enamido] butanedioic acid (BF142), improves baseline insulin secretion of MIN6 insulinoma cells. PLoS ONE. 15(9). e0236081–e0236081. 3 indexed citations
4.
Nagy, Lilla, Gyula Ujlaki, Gréta Kis, et al.. (2019). Olaparib induces browning of in vitro cultures of human primary white adipocytes. Biochemical Pharmacology. 167. 76–85. 21 indexed citations
5.
Lódi, Mária, Dániel Priksz, Gábor Áron Fülöp, et al.. (2019). Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy. Journal of Translational Medicine. 17(1). 229–229. 16 indexed citations
6.
Nagy, Lilla, et al.. (2019). Router-based IoT Security using Raspberry Pi. 1–6. 4 indexed citations
7.
Márton, Judit, Tamás Fodor, Lilla Nagy, et al.. (2018). PARP10 (ARTD10) modulates mitochondrial function. PLoS ONE. 13(1). e0187789–e0187789. 45 indexed citations
8.
Nagy, Lilla. (2017). Novel metabolic effects of glycogen phosphorylase inhibitors. University of Debrecen Electronic Archive (University of Debrecen). 1 indexed citations
9.
Nagy, Lilla, Judit Márton, András Vida, et al.. (2017). Glycogen phosphorylase inhibition improves beta cell function. British Journal of Pharmacology. 175(2). 301–319. 38 indexed citations
10.
Veréb, Gábor, et al.. (2017). HIGHLY EFFICIENT PURIFICATION OF FINELY DISPERSED OIL CONTAMINATED WATERS BY COAGULATION/FLOCCULATION METHOD AND EFFECTS ON MEMBRANE FILTRATION. Studia Universitatis Babeș-Bolyai Chemia. 259–270. 6 indexed citations
11.
Mühl, Diána, Bálint Nagy, Ákos Mérei, et al.. (2016). Perioperative time course of matrix metalloproteinase-9 (MMP-9), its tissue inhibitor TIMP-1 & S100B protein in carotid surgery. The Indian Journal of Medical Research. 143(2). 220–220. 7 indexed citations
12.
Fodor, Tamás, Magdolna Szántó, Omar Abdul‐Rahman, et al.. (2016). Combined Treatment of MCF-7 Cells with AICAR and Methotrexate, Arrests Cell Cycle and Reverses Warburg Metabolism through AMP-Activated Protein Kinase (AMPK) and FOXO1. PLoS ONE. 11(2). e0150232–e0150232. 51 indexed citations
13.
Abdul‐Rahman, Omar, Endre Kristóf, András Vida, et al.. (2016). AMP-Activated Kinase (AMPK) Activation by AICAR in Human White Adipocytes Derived from Pericardial White Adipose Tissue Stem Cells Induces a Partial Beige-Like Phenotype. PLoS ONE. 11(6). e0157644–e0157644. 29 indexed citations
14.
Bai, Péter, Lilla Nagy, Tamás Fodor, Lucas Liaudet, & Pál Pacher. (2014). Poly(ADP-ribose) polymerases as modulators of mitochondrial activity. Trends in Endocrinology and Metabolism. 26(2). 75–83. 91 indexed citations
16.
Szántó, Magdolna, Attila Brunyánszki, Judit Márton, et al.. (2013). Deletion of PARP-2 induces hepatic cholesterol accumulation and decrease in HDL levels. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(4). 594–602. 38 indexed citations
17.
Szántó, Magdolna, Attila Brunyánszki, Borbála Kiss, et al.. (2012). Poly(ADP-ribose) polymerase-2: emerging transcriptional roles of a DNA-repair protein. Cellular and Molecular Life Sciences. 69(24). 4079–4092. 72 indexed citations
18.
Nagy, Lilla, et al.. (1951). [Effect of pyramidon on O2 consumption of the rat].. PubMed. 3(3). 165–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026